首页> 美国卫生研究院文献>Journal of Lipid Research >Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles
【2h】

Diabetic nephropathy induces alterations in the glomerular and tubule lipid profiles

机译:糖尿病肾病引起肾小球和肾小管脂质分布改变

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Diabetic nephropathy (DN) is a major life-threatening complication of diabetes. Renal lesions affect glomeruli and tubules, but the pathogenesis is not completely understood. Phospholipids and glycolipids are molecules that carry out multiple cell functions in health and disease, and their role in DN pathogenesis is unknown. We employed high spatial resolution MALDI imaging MS to determine lipid changes in kidneys of eNOS−/− db/db mice, a robust model of DN. Phospholipid and glycolipid structures, localization patterns, and relative tissue levels were determined in individual renal glomeruli and tubules without disturbing tissue morphology. A significant increase in the levels of specific glomerular and tubular lipid species from four different classes, i.e., gangliosides, sulfoglycosphingolipids, lysophospholipids, and phosphatidylethanolamines, was detected in diabetic kidneys compared with nondiabetic controls. Inhibition of nonenzymatic oxidative and glycoxidative pathways attenuated the increase in lipid levels and ameliorated renal pathology, even though blood glucose levels remained unchanged. Our data demonstrate that the levels of specific phospho- and glycolipids in glomeruli and/or tubules are associated with diabetic renal pathology. We suggest that hyperglycemia-induced DN pathogenic mechanisms require intermediate oxidative steps that involve specific phospholipid and glycolipid species.
机译:糖尿病肾病(DN)是糖尿病的主要威胁生命的并发症。肾脏病变会影响肾小球和肾小管,但其发病机理尚不完全清楚。磷脂和糖脂是在健康和疾病中具有多种细胞功能的分子,在DN发病机理中的作用尚不清楚。我们采用了高空间分辨率的MALDI成像MS来确定eNOS -/- db / db小鼠(DN的一种健壮模型)肾脏的脂质变化。确定单个肾小球和肾小管的磷脂和糖脂结构,定位模式和相对组织水平,而不会干扰组织形态。与非糖尿病对照组相比,在糖尿病肾中检测到来自四个不同类别的特定肾小球和肾小管脂质种类的水平显着增加,即神经节苷脂,磺基糖鞘脂,溶血磷脂和磷脂酰乙醇胺。即使血糖水平保持不变,对非酶氧化和糖氧化途径的抑制也会减弱脂质水平的增加并改善肾脏病理。我们的数据表明,肾小球和/或肾小管中特定磷酸脂和糖脂的水平与糖尿病性肾病有关。我们建议高血糖诱导的DN致病机制需要涉及特定磷脂和糖脂种类的中间氧化步骤。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号